Patrick J. McEnany, Director at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 181,810 shares at $22.98 ($4.1M) on 2024-11-13, disclosed to the SEC on 2024-11-15.
Open-market sale of $4.1M CPRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.98 | 92,500 | $2.1M | 52.3% |
| 2 | $21.75 | 44,655 | $971K | 23.9% |
| 3 | $21.75 | 44,655 | $971K | 23.9% |
| Total | $22.38 avg | 181,810 | $4.1M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |
| CPRX | SELL | 2022-11-22 | $7.8M | — | Filing → |